Agilent Technologies, Inc.
A
Rank in Stocks
#501
Agilent Technologies, Inc. delivers specialized, application-focused... Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.
Share Price
$172.82
Last synced: 2026-10-16
Market Cap
$48.73B
Change (1 day)
-1.62%
Change (1 year)
21.77%
Country
US
Trade Agilent Technologies, Inc. (A)
Category
Healthcare
Number of shares outstanding for Agilent Technologies, Inc. (A)
Number of shares outstanding as of July 2026: 282.00M
According to Agilent Technologies, Inc. latest financial reports and stock price the company's current number of shares outstanding is 282.00M. At the end of October 2024 the company had 290.00M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Agilent Technologies, Inc. (A) from 2000 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 282.00M | -0.35% |
| 2025 | 283.00M | -2.41% |
| 2024 | 290.00M | -1.36% |
| 2023 | 294.00M | -1.67% |
| 2022 | 299.00M | -1.64% |
| 2021 | 304.00M | -1.62% |
| 2020 | 309.00M | -1.59% |
| 2019 | 314.00M | -2.18% |
| 2018 | 321.00M | -0.31% |
| 2017 | 322.00M | -1.23% |
| 2016 | 326.00M | -2.10% |
| 2015 | 333.00M | 0.00% |
| 2014 | 333.00M | -2.35% |
| 2013 | 341.00M | -2.01% |
| 2012 | 348.00M | 0.29% |
| 2011 | 347.00M | 0.00% |
| 2010 | 347.00M | 0.29% |
| 2009 | 346.00M | -4.68% |
| 2008 | 363.00M | -7.87% |
| 2007 | 394.00M | -8.58% |
| 2006 | 431.00M | -12.75% |
| 2005 | 494.00M | 2.28% |
| 2004 | 483.00M | 2.11% |
| 2003 | 473.00M | 1.72% |
| 2002 | 465.00M | 1.53% |
| 2001 | 458.00M | 2.00% |
| 2000 | 449.00M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 371.00M | 31.56% |
US
|
|
| 705.30M | 150.11% |
US
|
|
| 143.28M | -49.19% |
US
|
|
| - | - |
CN
|
|
| 80.10M | -71.60% |
US
|
